155 related articles for article (PubMed ID: 38323337)
1. Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy.
Dupont C; Burks AW; Fleischer DM; Bee KJ; Chainani S; Sampson HA
Expert Rev Clin Immunol; 2024 Jun; 20(6):623-633. PubMed ID: 38323337
[TBL] [Abstract][Full Text] [Related]
2. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
Fleischer DM; Shreffler WG; Campbell DE; Green TD; Anvari S; Assa'ad A; Bégin P; Beyer K; Bird JA; Brown-Whitehorn T; Byrne A; Chan ES; Cheema A; Chinthrajah S; Chong HJ; Davis CM; Ford LS; Gagnon R; Greenhawt M; Hourihane JO; Jones SM; Kim EH; Lange L; Lanser BJ; Leonard S; Mahler V; Maronna A; Nowak-Wegrzyn A; Oriel RC; O'Sullivan M; Petroni D; Pongracic JA; Prescott SL; Schneider LC; Smith P; Staab D; Sussman G; Wood R; Yang WH; Lambert R; Peillon A; Bois T; Sampson HA
J Allergy Clin Immunol; 2020 Oct; 146(4):863-874. PubMed ID: 32659313
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial.
Fleischer DM; Chinthrajah S; Scurlock AM; Campbell DE; Green TD; Bee KJ; Peillon A; Ocheltree T; Sampson HA
Allergy Asthma Proc; 2020 Sep; 41(5):326-335. PubMed ID: 32539908
[No Abstract] [Full Text] [Related]
4. From Skin to Solution: Exploring Epicutaneous Immunotherapy for Peanut Allergy-A Systematic Review and Meta-Analysis.
Banatwala UESS; Nasir MM; Javed R; Ahmed A; Farhan SA; Ajam A
Clin Rev Allergy Immunol; 2024 Apr; 66(2):125-137. PubMed ID: 38526693
[TBL] [Abstract][Full Text] [Related]
5. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.
Jones SM; Sicherer SH; Burks AW; Leung DY; Lindblad RW; Dawson P; Henning AK; Berin MC; Chiang D; Vickery BP; Pesek RD; Cho CB; Davidson WF; Plaut M; Sampson HA; Wood RA;
J Allergy Clin Immunol; 2017 Apr; 139(4):1242-1252.e9. PubMed ID: 28091362
[TBL] [Abstract][Full Text] [Related]
6. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
Fleischer DM; Greenhawt M; Sussman G; Bégin P; Nowak-Wegrzyn A; Petroni D; Beyer K; Brown-Whitehorn T; Hebert J; Hourihane JO; Campbell DE; Leonard S; Chinthrajah RS; Pongracic JA; Jones SM; Lange L; Chong H; Green TD; Wood R; Cheema A; Prescott SL; Smith P; Yang W; Chan ES; Byrne A; Assa'ad A; Bird JA; Kim EH; Schneider L; Davis CM; Lanser BJ; Lambert R; Shreffler W
JAMA; 2019 Mar; 321(10):946-955. PubMed ID: 30794314
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergy.
Fleischer DM; Spergel JM; Kim EH; Campbell DE; Green TD; Bee KJ; Lambert R; Ocheltree T; Sampson HA
Allergy Asthma Proc; 2020 Jul; 41(4):278-284. PubMed ID: 32517847
[No Abstract] [Full Text] [Related]
8. Epicutaneous immunotherapy with Viaskin
Stukus DR; Gupta R; Mack D; Mandelbaum L; Siri D; Hernandez-Trujillo V; Sampson HA
Immunotherapy; 2024 Jan; 16(1):5-13. PubMed ID: 38112107
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy approaches for peanut allergy.
Kim EH; Patel C; Burks AW
Expert Rev Clin Immunol; 2020 Feb; 16(2):167-174. PubMed ID: 31928251
[No Abstract] [Full Text] [Related]
10. Epicutaneous peanut patch device for the treatment of peanut allergy.
Langlois A; Graham F; Bégin P
Expert Rev Clin Immunol; 2019 May; 15(5):449-460. PubMed ID: 30864861
[TBL] [Abstract][Full Text] [Related]
11. Current state and advances in desensitization for peanut allergy in pediatric age.
Foti Randazzese S; Panasiti I; Caminiti L; Catamerò F; Landi M; De Filippo M; Votto M; Olcese R; Favuzza F; Giovannini M; Barberi S
Pediatr Allergy Immunol; 2024 Apr; 35(4):e14127. PubMed ID: 38646959
[TBL] [Abstract][Full Text] [Related]
12. Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.
Mondoulet L; Dioszeghy V; Puteaux E; Ligouis M; Dhelft V; Plaquet C; Dupont C; Benhamou PH
J Allergy Clin Immunol; 2015 Jun; 135(6):1546-57.e4. PubMed ID: 25583102
[TBL] [Abstract][Full Text] [Related]
13. Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.
Sampson HA; Shreffler WG; Yang WH; Sussman GL; Brown-Whitehorn TF; Nadeau KC; Cheema AS; Leonard SA; Pongracic JA; Sauvage-Delebarre C; Assa'ad AH; de Blay F; Bird JA; Tilles SA; Boralevi F; Bourrier T; Hébert J; Green TD; Gerth van Wijk R; Knulst AC; Kanny G; Schneider LC; Kowalski ML; Dupont C
JAMA; 2017 Nov; 318(18):1798-1809. PubMed ID: 29136445
[TBL] [Abstract][Full Text] [Related]
14. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
15. Peanut allergen powder (Palforzia).
Med Lett Drugs Ther; 2020 Mar; 62(1593):33-34. PubMed ID: 32555119
[No Abstract] [Full Text] [Related]
16. Advances in the management of peanut allergy (oral immunotherapy and epicutaneous immunotherapy).
Wang J
Allergy Asthma Proc; 2020 Jan; 41(1):5-9. PubMed ID: 31888777
[No Abstract] [Full Text] [Related]
17. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
Greenhawt M; Sindher SB; Wang J; O'Sullivan M; du Toit G; Kim EH; Albright D; Anvari S; Arends N; Arkwright PD; Bégin P; Blumchen K; Bourrier T; Brown-Whitehorn T; Cassell H; Chan ES; Ciaccio CE; Deschildre A; Divaret-Chauveau A; Dorris SL; Dorsey MJ; Eiwegger T; Erlewyn-Lajeunesse M; Fleischer DM; Ford LS; Garcia-Lloret M; Giovannini-Chami L; Hourihane JO; Jay N; Jones SM; Kerns LA; Kloepfer KM; Leonard S; Lezmi G; Lieberman JA; Lomas J; Makhija M; Parrish C; Peake J; Perrett KP; Petroni D; Pfützner W; Pongracic JA; Quinn P; Robison RG; Sanders G; Schneider L; Sharma HP; Trujillo J; Turner PJ; Tuttle K; Upton JE; Varshney P; Vickery BP; Vogelberg C; Wainstein B; Wood RA; Bee KJ; Campbell DE; Green TD; Rouissi R; Peillon A; Bahnson HT; Bois T; Sampson HA; Burks AW
N Engl J Med; 2023 May; 388(19):1755-1766. PubMed ID: 37163622
[TBL] [Abstract][Full Text] [Related]
18. Targeted allergen-specific immunotherapy within the skin improves allergen delivery to induce desensitization to peanut.
Landers JJ; Janczak KW; Shakya AK; Zarnitsyn V; Patel SR; Baker JR; Gill HS; O'Konek JJ
Immunotherapy; 2022 May; 14(7):539-552. PubMed ID: 35196877
[TBL] [Abstract][Full Text] [Related]
19. Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research.
Scurlock AM; Burks AW; Sicherer SH; Leung DYM; Kim EH; Henning AK; Dawson P; Lindblad RW; Berin MC; Cho CB; Davidson WF; Plaut M; Sampson HA; Wood RA; Jones SM;
J Allergy Clin Immunol; 2021 Mar; 147(3):992-1003.e5. PubMed ID: 33290772
[TBL] [Abstract][Full Text] [Related]
20. Treatment of gastric eosinophilia by epicutaneous immunotherapy in piglets sensitized to peanuts.
Mondoulet L; Kalach N; Dhelft V; Larcher T; Delayre-Orthez C; Benhamou PH; Spergel J; Sampson HA; Dupont C
Clin Exp Allergy; 2017 Dec; 47(12):1640-1647. PubMed ID: 28960628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
